Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.
Myeloma
auto- and xenografting
genetically engineered mouse models of human cancer
immune
immune pathogenesis
immunodeficient mice models
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
11
02
2021
accepted:
28
04
2021
entrez:
21
6
2021
pubmed:
22
6
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Mouse models of human cancer provide an important research tool for elucidating the natural history of neoplastic growth and developing new treatment and prevention approaches. This is particularly true for multiple myeloma (MM), a common and largely incurable neoplasm of post-germinal center, immunoglobulin-producing B lymphocytes, called plasma cells, that reside in the hematopoietic bone marrow (BM) and cause osteolytic lesions and kidney failure among other forms of end-organ damage. The most widely used mouse models used to aid drug and immunotherapy development rely on
Identifiants
pubmed: 34149703
doi: 10.3389/fimmu.2021.667054
pmc: PMC8206561
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
667054Subventions
Organisme : NCI NIH HHS
ID : R01 CA151354
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA204231
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA236814
Pays : United States
Informations de copyright
Copyright © 2021 Pisano, Cheng, Sun, Dhakal, D’Souza, Chhabra, Knight, Rao, Zhan, Hari and Janz.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Blood. 2012 Jul 12;120(2):376-85
pubmed: 22451422
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10987-92
pubmed: 16037207
J Immunol. 2018 May 15;200(10):3485-3494
pubmed: 29654211
Mol Cell Biol. 2001 Jan;21(1):310-8
pubmed: 11113205
PLoS One. 2015 May 28;10(5):e0127828
pubmed: 26020268
J Immunother. 2020 Feb/Mar;43(2):48-52
pubmed: 31693515
Haematologica. 2020 Mar;105(3):e111-e115
pubmed: 31221780
Blood. 2014 Nov 13;124(20):3043-51
pubmed: 25293776
Blood. 2005 Dec 1;106(12):3846-53
pubmed: 16081683
J Immunol. 2011 Feb 1;186(3):1840-8
pubmed: 21187443
Front Oncol. 2020 Aug 14;10:1439
pubmed: 32923397
Blood Adv. 2020 Sep 8;4(17):4180-4194
pubmed: 32886754
Blood Cancer J. 2019 Aug 12;9(8):64
pubmed: 31406111
Clin Cancer Res. 2020 Apr 1;26(7):1541-1554
pubmed: 31672768
Bone. 2015 Aug;77:57-68
pubmed: 25868800
Nature. 1975 Aug 7;256(5517):495-7
pubmed: 1172191
Clin Cancer Res. 2012 Nov 15;18(22):6260-70
pubmed: 23035210
Immunol Res. 2014 Aug;59(1-3):188-202
pubmed: 24845460
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1509-14
pubmed: 11805288
PLoS One. 2019 Sep 19;14(9):e0217345
pubmed: 31536492
Curr Opin Pharmacol. 2016 Jun;28:43-9
pubmed: 27018230
Bonekey Rep. 2016 Feb 03;5:772
pubmed: 26909147
Blood. 2014 Jun 12;123(24):3770-9
pubmed: 24782505
Nat Commun. 2020 Feb 7;11(1):798
pubmed: 32034142
EMBO J. 2012 Sep 12;31(18):3704-17
pubmed: 22903061
Front Genet. 2019 Aug 15;10:740
pubmed: 31475039
Blood. 2020 Nov 26;136(22):2491-2497
pubmed: 32735639
Blood. 2007 Jul 15;110(2):743-51
pubmed: 17405906
Nat Biotechnol. 2014 Apr;32(4):364-72
pubmed: 24633240
Cancer. 1985 Mar 1;55(5):1030-40
pubmed: 3967188
Nat Commun. 2020 Apr 21;11(1):1917
pubmed: 32317634
Sci Rep. 2016 Mar 10;6:22760
pubmed: 26961797
Lancet. 2015 May 30;385(9983):2197-208
pubmed: 25540889
J Immunol. 1979 Feb;122(2):609-13
pubmed: 368243
Blood. 2016 Sep 1;128(9):1226-33
pubmed: 27458004
Semin Oncol. 2002 Dec;29(6 Suppl 17):26-33
pubmed: 12520482
Clin Cancer Res. 2011 Apr 1;17(7):1692-700
pubmed: 21325290
Blood Adv. 2017 Nov 21;1(25):2375-2385
pubmed: 29296887
Cancer Res. 2008 Oct 15;68(20):8456-64
pubmed: 18922919
Sci Rep. 2018 Oct 9;8(1):15030
pubmed: 30301958
Blood. 2020 Dec 10;136(24):2731-2740
pubmed: 32645135
Blood. 2007 Mar 1;109(5):2106-11
pubmed: 17068150
Blood. 1992 Apr 1;79(7):1704-11
pubmed: 1558966
Clin Exp Immunol. 2012 Nov;170(2):167-77
pubmed: 23039887
Cell Rep. 2013 May 30;3(5):1389-97
pubmed: 23643536
Trends Biotechnol. 2018 Mar;36(3):242-251
pubmed: 29310843
Blood. 2018 Oct 18;132(16):1629-1630
pubmed: 30337318
PLoS One. 2013;8(2):e55841
pubmed: 23409060
J Autoimmun. 2016 Jan;66:76-88
pubmed: 26403950
Blood. 2003 Mar 1;101(5):1919-27
pubmed: 12424201
Cancer Cell. 2018 Apr 9;33(4):634-648.e5
pubmed: 29551594
Front Oncol. 2018 Dec 11;8:566
pubmed: 30619733
Blood. 2018 Oct 18;132(16):1689-1694
pubmed: 29986909
Br J Haematol. 2009 Mar;144(5):686-95
pubmed: 19133978
Leuk Lymphoma. 2018 Feb;59(2):288-299
pubmed: 28592156
Mol Ther Oncolytics. 2020 Jun 24;18:171-188
pubmed: 32695875
Blood. 2004 Apr 1;103(7):2779-86
pubmed: 14656874
Clin Cancer Res. 2005 Jun 1;11(11):4251-8
pubmed: 15930364
JCI Insight. 2019 Aug 8;4(15):
pubmed: 31391340
PLoS One. 2013 Jul 22;8(7):e70554
pubmed: 23894671
Immunol Rev. 2003 Aug;194:177-95
pubmed: 12846815
Front Immunol. 2019 Aug 02;10:1596
pubmed: 31428081
PLoS One. 2013 May 31;8(5):e65075
pubmed: 23741460
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):232-5
pubmed: 1729694
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
Blood. 2009 May 28;113(22):5418-22
pubmed: 19234139
Haematologica. 2020 Jul 23;105(10):2358-2367
pubmed: 33054076
Br J Cancer. 2000 Apr;82(7):1261-5
pubmed: 10755398
Nat Commun. 2018 Dec 3;9(1):4832
pubmed: 30510245
Clin Lymphoma. 2001 Dec;2(3):148-54
pubmed: 11779291
J Natl Cancer Inst. 1975 Jun;54(6):1413-7
pubmed: 1133851
Cancer Res. 2003 Dec 15;63(24):8656-63
pubmed: 14695177
Blood Cancer J. 2013 Nov 01;3:e156
pubmed: 24185503
Sci Transl Med. 2016 Aug 24;8(353):353ra113
pubmed: 27559096
Immunotargets Ther. 2020 Oct 14;9:201-215
pubmed: 33117743
Trends Immunol. 2018 Sep;39(9):748-763
pubmed: 30077656
Br J Haematol. 2006 Sep;134(6):573-89
pubmed: 16938117
Nat Rev Immunol. 2017 Feb;17(2):97-111
pubmed: 27748397
Leukemia. 2020 Oct;34(10):2754-2765
pubmed: 32123307
Cell. 1982 Dec;31(2 Pt 1):443-52
pubmed: 6819085
Leukemia. 2008 Feb;22(2):406-13
pubmed: 18046446
Haematologica. 2011 Apr;96(4):574-82
pubmed: 21173094
Oncotarget. 2012 Oct;3(10):1246-58
pubmed: 23100393
JCI Insight. 2019 Apr 23;5:
pubmed: 31013254
Leukemia. 2017 Oct;31(10):2114-2121
pubmed: 28232741
J Immunother Cancer. 2019 Nov 14;7(1):301
pubmed: 31727148
Nat Rev Dis Primers. 2017 Jul 20;3:17046
pubmed: 28726797
Cancer Cell. 2008 Feb;13(2):167-80
pubmed: 18242516
JCI Insight. 2019 Jun 13;5:
pubmed: 31194697
Blood. 1999 Mar 1;93(5):1697-706
pubmed: 10029599
Curr Hematol Malig Rep. 2019 Apr;14(2):119-126
pubmed: 30848424
Mol Ther Methods Clin Dev. 2020 Jan 25;17:378-392
pubmed: 32128342
J Clin Invest. 2004 Jun;113(12):1763-73
pubmed: 15199411
Leukemia. 2011 Apr;25(4):707-11
pubmed: 21233838
BMC Cancer. 2012 May 29;12:203
pubmed: 22642622
Oncotarget. 2015 Nov 3;6(34):36032-40
pubmed: 26447613
Eur J Haematol Suppl. 1989;51:70-5
pubmed: 2516809
Immunology. 1969 Sep;17(3):481-7
pubmed: 4900765
Blood. 2006 Sep 15;108(6):2020-8
pubmed: 16728703
Stem Cells. 2011 Feb;29(2):263-73
pubmed: 21732484
BMC Cancer. 2020 Nov 4;20(1):1063
pubmed: 33148223
PLoS One. 2013 Nov 06;8(11):e79939
pubmed: 24223204
Sci Rep. 2017 Apr 03;7:45839
pubmed: 28368009
Am J Hematol. 2009 Jan;84(1):6-14
pubmed: 18980173
Oncotarget. 2018 Apr 13;9(28):20119-20133
pubmed: 29732008
J Clin Oncol. 2020 Apr 10;38(11):1126-1137
pubmed: 31652094
Biochem Biophys Res Commun. 2004 Jan 9;313(2):258-62
pubmed: 14684154
Methods Mol Med. 2005;113:183-90
pubmed: 15968103
Blood Adv. 2020 Oct 13;4(19):4593-4604
pubmed: 32986791
Blood Adv. 2019 Mar 12;3(5):797-812
pubmed: 30850386
Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-6
pubmed: 32223666
Blood. 2017 Jun 22;129(25):3294-3303
pubmed: 28483761
Neoplasma. 1991;38(5):467-74
pubmed: 1956464
Leukemia. 2016 Apr;30(4):962-6
pubmed: 26202932
Blood. 2020 Nov 19;136(21):2416-2427
pubmed: 32603414
J Immunother Cancer. 2019 Feb 8;7(1):37
pubmed: 30736857
Nat Rev Immunol. 2002 Dec;2(12):945-56
pubmed: 12461567
J Clin Invest. 2020 Apr 1;130(4):1565-1575
pubmed: 32149732
J Clin Invest. 2015 Jul 1;125(7):2904
pubmed: 26075821
Cancer Res. 2012 May 1;72(9):2183-9
pubmed: 22374979
J Cell Physiol. 2018 May;233(5):3723-3728
pubmed: 28598567
Cancer Res. 2007 May 1;67(9):4069-78
pubmed: 17483317
Leukemia. 2019 May;33(5):1273-1277
pubmed: 30787429
EMBO J. 1990 Mar;9(3):897-905
pubmed: 2155783
Clin Cancer Res. 2013 Jul 1;19(13):3640-8
pubmed: 23685836
Nature. 1969 Jun 7;222(5197):994-5
pubmed: 5789334
Curr Opin Biotechnol. 2020 Jun;63:151-156
pubmed: 32070860
PLoS One. 2012;7(12):e51892
pubmed: 23284805
Br J Cancer. 1996 Jun;73(12):1463-5
pubmed: 8664113
Leukemia. 2015 Feb;29(2):474-82
pubmed: 24962017
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14982-7
pubmed: 14634209
Blood Cancer J. 2014 Jun 13;4:e217
pubmed: 24927406
J Immunol. 1994 Oct 1;153(7):3123-34
pubmed: 8089490
J Transl Med. 2016 Sep 06;14:259
pubmed: 27599546
J Clin Oncol. 2009 Oct 20;27(30):5008-14
pubmed: 19720894
Blood Adv. 2020 Jun 23;4(12):2595-2605
pubmed: 32544236
Blood. 1997 Jul 15;90(2):754-65
pubmed: 9226176
Br J Cancer. 1987 Nov;56(5):555-60
pubmed: 3426918
Cancers (Basel). 2020 Jul 22;12(8):
pubmed: 32707884
Biol Blood Marrow Transplant. 2011 Aug;17(8):1133-45
pubmed: 21536144
PLoS One. 2013;8(2):e57641
pubmed: 23437401
Nat Rev Cancer. 2020 Jul;20(7):398-411
pubmed: 32488200
Oncoimmunology. 2018 Jul 23;7(10):e1484981
pubmed: 30288346
J Oncol. 2019 Apr 10;2019:2186494
pubmed: 31093282
J Exp Med. 2016 Aug 22;213(9):1705-22
pubmed: 27455953
J Clin Pathol. 2016 Feb;69(2):97-101
pubmed: 26598624
Cancer Cell. 2007 Apr;11(4):349-60
pubmed: 17418411
Oncotarget. 2016 Jun 21;7(25):37931-37943
pubmed: 27177328
Mol Cancer Ther. 2009 Sep;8(9):2616-24
pubmed: 19723891
Front Immunol. 2018 Sep 26;9:2204
pubmed: 30319648
Eur J Haematol. 2019 Feb;102(2):182-190
pubmed: 30485563
N Engl J Med. 1999 Nov 18;341(21):1565-71
pubmed: 10564685
J Immunol. 2013 Jun 1;190(11):5620-8
pubmed: 23616570
J Clin Invest. 2014 Dec;124(12):5263-74
pubmed: 25384216
Blood. 2014 Aug 14;124(7):1099-109
pubmed: 24986687
Leukemia. 2014 Aug;28(8):1725-1735
pubmed: 24518206
Blood. 2018 Oct 18;132(16):1675-1688
pubmed: 30154111
Exp Hematol. 2004 Nov;32(11):1064-72
pubmed: 15539084
Cancer J. 2019 Jan/Feb;25(1):38-44
pubmed: 30694858
Oncoimmunology. 2019 Apr 13;8(7):1599636
pubmed: 31143521
Br J Cancer. 1992 Dec;66(6):1088-93
pubmed: 1457349
Cancer Immunol Immunother. 2019 Nov;68(11):1865-1873
pubmed: 31448380
Genome Res. 2015 Apr;25(4):478-87
pubmed: 25644835
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):11802-11807
pubmed: 30373817
J Clin Invest. 2018 Jun 1;128(6):2487-2499
pubmed: 29558366
Blood. 1998 Oct 15;92(8):2908-13
pubmed: 9763577
Hematol Oncol. 2019 Jun;37 Suppl 1:62-65
pubmed: 31187526
Blood. 2021 Jan 7;137(1):61-74
pubmed: 32640012
Blood. 2010 Mar 4;115(9):1746-54
pubmed: 20018915
Mamm Genome. 2019 Jun;30(5-6):123-142
pubmed: 30847553
Annu Rev Immunol. 2013;31:635-674
pubmed: 23330956
Leukemia. 2010 Jun;24(6):1121-7
pubmed: 20410922
Cancer Immunol Immunother. 2012 Apr;61(4):561-71
pubmed: 22002243
Blood. 2021 Apr 8;137(14):1905-1919
pubmed: 33751108
Cancer Res. 2011 Jan 15;71(2):339-48
pubmed: 21224354
Nature. 1962 Mar 17;193:1086-7
pubmed: 14488296
Exp Hematol. 2012 Mar;40(3):216-27
pubmed: 22120021
J Clin Invest. 2019 Jan 2;129(1):106-121
pubmed: 30300141
J Immunol. 2008 Sep 1;181(5):3714-24
pubmed: 18714048
Lancet Oncol. 2018 Dec;19(12):1641-1653
pubmed: 30442502
Leukemia. 2016 May;30(5):1216-20
pubmed: 26449664
Leukemia. 2004 Nov;18(11):1891-7
pubmed: 15385929
J Immunol. 1991 Nov 15;147(10):3632-7
pubmed: 1682379
PLoS One. 2014 Oct 01;9(10):e109018
pubmed: 25272036
Blood. 2021 Jan 7;137(1):16-19
pubmed: 33024991
Nat Med. 2016 Nov;22(11):1351-1357
pubmed: 27723723
Nat Med. 2016 Dec;22(12):1411-1420
pubmed: 27841872
PLoS One. 2014 Nov 21;9(11):e113764
pubmed: 25415267
Blood. 2016 Sep 29;128(13):1735-44
pubmed: 27516441
Blood. 2016 Feb 11;127(6):681-95
pubmed: 26631114
Leukemia. 2021 Mar;35(3):752-763
pubmed: 32632095
Leukemia. 2020 Jan;34(1):245-256
pubmed: 31439945
Blood Adv. 2019 Feb 26;3(4):541-551
pubmed: 30782613
Nat Rev Cancer. 2012 Jan 19;12(2):144-9
pubmed: 22257951
Cancer Res. 2005 Dec 15;65(24):11712-20
pubmed: 16357183
Cancer Res. 1999 Sep 15;59(18):4546-50
pubmed: 10493504
Blood. 2006 Mar 15;107(6):2432-9
pubmed: 16291589
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):380-388
pubmed: 33275738
Leukemia. 2020 Apr;34(4):1197-1201
pubmed: 31719682
Neoplasma. 1991;38(5):457-66
pubmed: 1956463
J Immunother Cancer. 2020 Sep;8(2):
pubmed: 32900861
Am J Pathol. 1988 Sep;132(3):593-7
pubmed: 3414786
Gene Ther. 2011 May;18(5):509-16
pubmed: 21209626
Front Immunol. 2018 Feb 02;9:152
pubmed: 29456539